R. Crabbé
Impact in
- Hepatology top 2%
- Hepatitis C virus research
- Virology top 10%
- HIV Research and Treatment
Papers in
- Hepatology 10
- Hepatitis C virus research 10
-
- Signaling Pathways in Disease 6
- Co-authors
- Robert Flisiak (10 shared papers)Jean‐Maurice Dumont (3 shared papers)Valerie Nicolas‐Métral (4 shared papers)Piétro Scalfaro (7 shared papers)Andrzej Horban (7 shared papers)Pierre Grosgurin (3 shared papers)Hervé Porchet (2 shared papers)Wiesław Kryczka (4 shared papers)
- Journals
- Journal of Hepatology (8 papers)Annals of Allergy Asthma & Immunology (3 papers)Hepatology (2 papers)Expert Opinion on Investigational Drugs (2 papers)British Journal of Clinical Pharmacology (2 papers)
- Partner nations
- SwitzerlandUnited StatesPoland
In The Last Decade
R. Crabbé
29 papers receiving 598 citations
Peers
Comparison fields: 5 of 62
- Hepatology 398
- Virology 52
- Epidemiology 293
- Infectious Diseases 79
- Molecular Biology 212
Countries citing papers authored by R. Crabbé
This map shows the geographic impact of R. Crabbé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Crabbé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Crabbé more than expected).
Fields of papers citing papers by R. Crabbé
This network shows the impact of papers produced by R. Crabbé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Crabbé. The network helps show where R. Crabbé may publish in the future.
Co-authors
The 25 scholars most cited alongside R. Crabbé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 30 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 179 | |
| 2 | 2009 | 168 | |
| 3 | 2011 | 46 | |
| 4 | 2007 | 38 | |
| 5 | 2008 | 33 | |
| 6 | 2008 | 20 | |
| 7 | 2009 | 19 | |
| 8 | 2008 | 16 | |
| 9 | 1996 | 14 | |
| 10 | ALISPORIVIR - A HOST-TARGETING ANTIVIRAL, PROVIDES LOW VIRAL BREAKTHROUGH RATE AND HIGH BARRIER TO RESISTANCE IN HCV GENOTYPE 1 TREATMENT-NAiVE PATIENTS IN THE PHASE IIB ESSENTIAL STUDY | 2011 | 10 |
| 11 | 2006 | 9 | |
| 12 | 1996 | 9 | |
| 13 | 2007 | 8 | |
| 14 | 2009 | 6 | |
| 15 | 2010 | 5 | |
| 16 | 2007 | 4 | |
| 17 | 2021 | 4 | |
| 18 | Pharmacokinetics of lubeluzole (Prosynap) after single intravenous doses in healthy subjects. | 1998 | 3 |
| 19 | 2016 | 3 | |
| 20 | 2008 | 3 |
About R. Crabbé
R. Crabbé is a scholar working on Hepatology, Molecular Biology, Epidemiology, Hematology and Infectious Diseases, having authored 30 papers that have together received 613 indexed citations. Recurring topics across this work include Hepatitis C virus research (10 papers), Hepatitis B Virus Studies (6 papers), Signaling Pathways in Disease (6 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (3 papers), Growth Hormone and Insulin-like Growth Factors (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers), Antifungal resistance and susceptibility (2 papers) and Adenosine and Purinergic Signaling (2 papers). The work is most often cited by research in Hepatology (398 citations), Virology (52 citations), Epidemiology (293 citations), Infectious Diseases (79 citations) and Molecular Biology (212 citations). R. Crabbé has collaborated with scholars based in Switzerland, United States and Poland. Frequent co-authors include Robert Flisiak, Jean‐Maurice Dumont, Valerie Nicolas‐Métral, Piétro Scalfaro, Andrzej Horban, Pierre Grosgurin, Hervé Porchet, Wiesław Kryczka, G. Mazzella and Jorge S. Liz. Their work appears in journals such as Journal of Hepatology, Annals of Allergy Asthma & Immunology, Hepatology, Expert Opinion on Investigational Drugs and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.